Income Tax Expense (Benefit) in USD of ARROWHEAD PHARMACEUTICALS, INC. from 2014 to 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2014 to 2025.
  • ARROWHEAD PHARMACEUTICALS, INC. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2025 was -$437K.
  • ARROWHEAD PHARMACEUTICALS, INC. Income Tax Expense (Benefit) for the twelve months ending 30 Jun 2025 was $4.73M.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Income Tax Expense (Benefit) for 2025 was $21.4M.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Income Tax Expense (Benefit) for 2024 was -$2.77K, a 199% decline from 2023.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Income Tax Expense (Benefit) for 2023 was $2.78K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $4.73M -$437K -$437K 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $5.17M $1.75M* +$1.75M 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $3.41M $103K +$3.42M 01 Oct 2024 31 Dec 2024 10-Q 10 Feb 2025
Q3 2024 -$2.77K $3.31M +$4.07M 01 Jul 2024 30 Sep 2024 10-K 25 Nov 2025
Q2 2024 -$4.07M $0 -$742K -100% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$3.33M $0 $0 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 -$3.33M -$3.31M* -$3.33M 01 Oct 2023 31 Dec 2023 10-Q 10 Feb 2025
Q3 2023 $2.78K -$756K 01 Jul 2023 30 Sep 2023 10-K 25 Nov 2025
Q2 2023 $742K +$742K 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $17K +$17K 01 Oct 2022 31 Dec 2022 10-Q 06 Feb 2024
Q2 2022 $0 $0 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 $0 01 Oct 2021 31 Dec 2021 10-Q 06 Feb 2023
Q2 2021 $0 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q3 2019 $174K $174K +$172K +7150% 01 Jul 2019 30 Sep 2019 10-K 22 Nov 2021
Q2 2019 $2.4K $0 $0 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2019
Q1 2019 $2.4K $0 $0 01 Jan 2019 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $2.4K $0 $0 01 Oct 2018 31 Dec 2018 10-Q 07 Feb 2019
Q3 2018 $2.4K $2.4K 01 Jul 2018 30 Sep 2018 10-K 23 Nov 2020
Q2 2018 $0 01 Apr 2018 30 Jun 2018 10-Q 05 Aug 2019
Q1 2018 $0 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q4 2017 $0 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019

ARROWHEAD PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $21.4M* +$21.4M 01 Oct 2024 30 Sep 2025 10-K 25 Nov 2025
2024 -$2.77K -$5.55K -199% 01 Oct 2023 30 Sep 2024 10-K 25 Nov 2025
2023 $2.78K -$3.78M 01 Oct 2022 30 Sep 2023 10-K 25 Nov 2025
2022 $3.79M* +$3.78M 01 Oct 2021 30 Sep 2022 10-K 26 Nov 2024
2021 $2K $0 0% 01 Oct 2020 30 Sep 2021 10-K 29 Nov 2023
2020 $2K -$172K -98.9% 01 Oct 2019 30 Sep 2020 10-K 28 Nov 2022
2019 $174K +$172K +7150% 01 Oct 2018 30 Sep 2019 10-K 22 Nov 2021
2018 $2.4K $0 0% 01 Oct 2017 30 Sep 2018 10-K 23 Nov 2020
2017 $2.4K $0 0% 01 Oct 2016 30 Sep 2017 10-K 25 Nov 2019
2016 $2.4K $0 0% 01 Oct 2015 30 Sep 2016 10-K 11 Dec 2018
2015 $2.4K -$2.9K -54.7% 01 Oct 2014 30 Sep 2015 10-K 12 Dec 2017
2014 $5.3K 01 Oct 2013 30 Sep 2014 10-K 14 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.